ARDX NASDAQ
Ardelyx, Inc.
1W: -6.5%
1M: -12.0%
3M: -40.0%
YTD: -51.2%
1Y: -40.5%
3Y: -15.7%
5Y: +185.7%
$3.00
+0.00 (+0.00%)
Weekly Expected Move ±5.3%
$3
$3
$3
$3
$3
Credit Risk of going bust: higher than 69% of companies Debt: 25.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.11 (down 96%), Ardelyx, Inc. would be worth roughly what it owes.
Total debt $256.2M against a stock market value of $747.6M.
Distance to default 3.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $125.9M (short-term plus half of long-term), stock volatility 60.9%; Altman Z'' -2.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.11 (down 96%), Ardelyx, Inc. would be worth roughly what it owes.
Total debt $256.2M against a stock market value of $747.6M.
Distance to default 3.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $125.9M (short-term plus half of long-term), stock volatility 60.9%; Altman Z'' -2.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-08-17
Earliest Filing
2024-10-09
Latest Filing
partner: 5
supplier: 1
investor: 1
licensee: 1
Counterparties (Filed by ARDX)
8 relationshipsCompanies named in ARDX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| BMR-Pacific Research Center LP | — | partner | Landlord for the New Fremont Lease agreement | 2024-10-09 | View |
| 34175 Ardenwood Venture, LLC | — | partner | Landlord for the Existing Fremont Lease amendment | 2024-10-09 | View |
| Catalent Pharma Solutions, LLC | — | supplier | Commercial Supply Agreement for manufacturing, tableting, testing, and packaging of IBSRELA® | 2024-08-12 | View |
| Jefferies LLC | JEF | partner | Acted as sales agent for an open market sale agreement to offer and sell common stock. | 2023-01-24 | View |
| HealthCare Royalty Partners IV, L.P. | — | investor | Acquired royalty and sales milestone interest from Ardelyx, Inc. | 2022-06-30 | View |
| Kyowa Kirin Co., Ltd. | — | partner | Holds the underlying License Agreement with Ardelyx, Inc. for tenapanor sales in Japan. | 2022-06-30 | View |
| Kyowa Kirin Co., Ltd. | — | licensee | Agreed to reduce royalty rates and pay up to $40 million to Ardelyx, Inc. under an amended license agreement. | 2022-04-11 | View |
| Jefferies LLC | JEF | partner | Sales Agent for Open Market Sale Agreement | 2021-08-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-17 | Other Events | View | |
| 2026-08-06 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-02 | Financial Obligation; Exhibits | View | |
| 2026-06-17 | Officer/Director Change; Shareholder Vote | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-02-19 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-08 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-12-17 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-14 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-04 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-07-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-18 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-29 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-02-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2024-11-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-10-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-09 | Entry into Material Definitive Agreement | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR